miRNA therapeutics targeting RAS networks

High anti-tumor activity for wide range of RAS mutated cancers by chemically-modified miR-143#12 (Tumor-suppressor miRNA)

Improving the efficiency of exogenous mRNA expression

Overcoming the challenges of mRNA medicine by improving translation efficiency

A whole-animal platform for exploring pancreatic cancer drug and combination therapy thereby

Drosophila models for human PDAC genotype

Antisense Oligonucleotide Therapy for Liver Cancer

-Two independent antisense oligonucleotides (ASOs) targeting GREB1 and Arl4c gene-

Cancer vaccine (gene therapy) using adenoviral vector (Ad-REIC)